|
"pan sl"的相关文件
显示项目 1-10 / 123 (共13页)
1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目
| 國家衛生研究院 |
2023-02-07 |
Development of furanopyrimidine-based orally active third- generation EGFR inhibitors for the treatment of non-small cell lung cancer
|
Li, MC;Coumar, MS;Lin, SY;Lin, YS;Huang, GL;Chen, CH;Lien, TW;Wu, YW;Chen, YT;Chen, CP;Huang, YC;Yeh, KC;Yang, CM;Kalita, B;Pan, SL;Hsu, TA;Yeh, TK;Chen, CT;Hsieh, HP |
| 國家衛生研究院 |
2022-05-13 |
Evaluating the effectiveness of population-based breast cancer service screening: An analysis of parsimonious patient survival information with the time-varying Cox model
|
Chang, WJ;Jen, HH;Lin, KC;Cheng, TC;Chuang, SY;Pan, SL;Chen, HH;Yen, MF |
| 國家衛生研究院 |
2022-02-07 |
Development of furanopyrimidine-based orally active third-generation EGFR inhibitors for the treatment of non-small cell lung cancer
|
Li, MC;Coumar, MS;Lin, SY;Lin, YS;Huang, GL;Chen, CH;Lien, TW;Wu, YW;Chen, YT;Chen, CP;Huang, YC;Yeh, KC;Yang, CM;Kalita, B;Pan, SL;Hsu, TA;Yeh, TK;Chen, CT;Hsieh, HP |
| 中山醫學大學 |
2020 |
Isolation of anti-VEGF monoclonal antibodies with neutralizing effects from an Astragalus-induced immune antibody library
|
Lee, YC; Huang, HT; Chang, CD; Chen, CT; Lin, TY; Yang, TW; Chang, FL; Lu, MK; Chiou, CT; Chen, WC; Pan, SL; Tsai, KC |
| 臺大學術典藏 |
2018-09-10T06:15:46Z |
Reduction of disability after stroke is a more informative predictor of long-time survival than initial disability status
|
Pan, S.-L. and Wu, S.-C. and Lee, T.-K. and Chen, T.H.-H.; Pan, SL;Wu, SC;Lee, TK;Chen, TH; Pan, SL; HSIU-HSI CHEN; SHIN-LIANG PAN; Wu, SC; Lee, TK; Chen, TH |
| 國家衛生研究院 |
2018-04 |
4-Bromophenylhydrazinyl benzenesulfonylphenylureas as indoleamine 2,3-dioxygenase inhibitors with in vivo target inhibition and anti-tumor efficacy
|
Lin, SY;Yeh, TK;Song, JS;Hung, MS;Cheng, MF;Liao, FY;Li, AS;Cheng, SY;Lin, LM;Chiu, CH;Wu, MH;Lin, YJ;Hsiao, W;Sun, M;Wang, YH;Huang, CH;Tang, YC;Chang, HH;Huang, ZT;Chao, YS;Shih, C;Pan, SL;Wu, SY;Kuo, CC;Ueng, SH |
| 國家衛生研究院 |
2016-12 |
Glucocorticoids may compromise the effect of gefitinib in non-small cell lung cancer
|
Wang, HY;Chang, YL;Cheng, CC;Chao, MW;Lin, SI;Pan, SL;Hsu, CC;Liu, TW;Cheng, HC;Tseng, CP;Liu, SJ;Tsai, HJ;Chang, HY;Hsu, JT |
| 國家衛生研究院 |
2016-12 |
Phenyl benzenesulfonylhydrazides: Selective indoleamine 2,3-dioxygenase inhibitors with potent in vivo pharmacodynamic activity and antitumor efficacy
|
Ueng, SH;Yeh, TK;Song, JS;Wu, SY;Kuo, CC;Shih, C;Pan, SL;Hung, MS |
| 國家衛生研究院 |
2016-01 |
Phenyl benzenesulfonylhydrazides exhibit selective Indoleamine 2,3-Dioxygenase inhibition with potent in vivo pharmacodynamic activity and antitumor efficacy
|
Lin, SY;Yeh, TK;Kuo, CC;Song, JS;Cheng, MF;Liao, FY;Chao, MW;Huang, HL;Chen, YL;Yang, CY;Wu, MH;Hsieh, CL;Hsiao, WC;Peng, YH;Wu, JS;Lin, LM;Sun, MW;Chao, YS;Shih, C;Wu, SY;Pan, SL;Hung, MS;Ueng, SH |
| 國家衛生研究院 |
2015-01 |
1-Arylsulfonyl-5-(N-hydroxyacrylamide)tetrahydroquinolines as potent histone deacetylase inhibitors suppressing the growth of prostate cancer cells
|
Liu, YM;Lee, HY;Chen, CH;Lee, CH;Wang, LT;Pan, SL;Lai, MJ;Yeh, TK;Liou, JP |
显示项目 1-10 / 123 (共13页)
1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目
|
